Industry Research Reports

Home > Reports > Pharma & Healthcare > Vaccine for Non-infectious Meningitis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Vaccine for Non-infectious Meningitis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 104 Pages

Report ld: 2333633

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.

The global market for Vaccine for Non-infectious Meningitis was estimated to be worth US$ 1 million in 2023 and is forecast to a readjusted size of US$ 2 million by 2030 with a CAGR of 12.0% during the forecast period 2024-2030

Vaccine for Non-infectious Meningitis Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine for Non-infectious Meningitis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Vaccine for Non-infectious Meningitis by region & country, by Type, and by Application.

The Vaccine for Non-infectious Meningitis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Non-infectious Meningitis.

Market Segmentation

Report Metric
Details
Report Title
Vaccine for Non-infectious Meningitis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 2 million
CAGR(2024-2030)
12%
Market Size Available for Years
2019-2030
Global Vaccine for Non-infectious Meningitis Companies Covered
Serum Institute, Sanofi SA, Pfizer, Nuron Biotech, JN-International Medical
Global Vaccine for Non-infectious Meningitis Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccine for Non-infectious Meningitis Market, Segment by Type
Polysaccharide Vaccines

Conjugate Vaccines

Combination Vaccines

Men B Vaccines
Global Vaccine for Non-infectious Meningitis Market, Segment by Application
Meningitis

Septicemia

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vaccine for Non-infectious Meningitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Vaccine for Non-infectious Meningitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Vaccine for Non-infectious Meningitis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Vaccine for Non-infectious Meningitis Product Introduction
    1.2 Global Vaccine for Non-infectious Meningitis Market Size Forecast
        1.2.1 Global Vaccine for Non-infectious Meningitis Sales Value (2019-2030)
        1.2.2 Global Vaccine for Non-infectious Meningitis Sales Volume (2019-2030)
        1.2.3 Global Vaccine for Non-infectious Meningitis Sales Price (2019-2030)
    1.3 Vaccine for Non-infectious Meningitis Market Trends & Drivers
        1.3.1 Vaccine for Non-infectious Meningitis Industry Trends
        1.3.2 Vaccine for Non-infectious Meningitis Market Drivers & Opportunity
        1.3.3 Vaccine for Non-infectious Meningitis Market Challenges
        1.3.4 Vaccine for Non-infectious Meningitis Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Vaccine for Non-infectious Meningitis Players Revenue Ranking (2023)
    2.2 Global Vaccine for Non-infectious Meningitis Revenue by Company (2019-2024)
    2.3 Global Vaccine for Non-infectious Meningitis Players Sales Volume Ranking (2023)
    2.4 Global Vaccine for Non-infectious Meningitis Sales Volume by Company Players (2019-2024)
    2.5 Global Vaccine for Non-infectious Meningitis Average Price by Company (2019-2024)
    2.6 Key Manufacturers Vaccine for Non-infectious Meningitis Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Vaccine for Non-infectious Meningitis Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Vaccine for Non-infectious Meningitis
    2.9 Vaccine for Non-infectious Meningitis Market Competitive Analysis
        2.9.1 Vaccine for Non-infectious Meningitis Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Vaccine for Non-infectious Meningitis Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Non-infectious Meningitis as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Polysaccharide Vaccines
        3.1.2 Conjugate Vaccines
        3.1.3 Combination Vaccines
        3.1.4 Men B Vaccines
    3.2 Global Vaccine for Non-infectious Meningitis Sales Value by Type
        3.2.1 Global Vaccine for Non-infectious Meningitis Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Vaccine for Non-infectious Meningitis Sales Value, by Type (2019-2030)
        3.2.3 Global Vaccine for Non-infectious Meningitis Sales Value, by Type (%) (2019-2030)
    3.3 Global Vaccine for Non-infectious Meningitis Sales Volume by Type
        3.3.1 Global Vaccine for Non-infectious Meningitis Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Vaccine for Non-infectious Meningitis Sales Volume, by Type (2019-2030)
        3.3.3 Global Vaccine for Non-infectious Meningitis Sales Volume, by Type (%) (2019-2030)
    3.4 Global Vaccine for Non-infectious Meningitis Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Meningitis
        4.1.2 Septicemia
        4.1.3 Others
    4.2 Global Vaccine for Non-infectious Meningitis Sales Value by Application
        4.2.1 Global Vaccine for Non-infectious Meningitis Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Vaccine for Non-infectious Meningitis Sales Value, by Application (2019-2030)
        4.2.3 Global Vaccine for Non-infectious Meningitis Sales Value, by Application (%) (2019-2030)
    4.3 Global Vaccine for Non-infectious Meningitis Sales Volume by Application
        4.3.1 Global Vaccine for Non-infectious Meningitis Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Vaccine for Non-infectious Meningitis Sales Volume, by Application (2019-2030)
        4.3.3 Global Vaccine for Non-infectious Meningitis Sales Volume, by Application (%) (2019-2030)
    4.4 Global Vaccine for Non-infectious Meningitis Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Vaccine for Non-infectious Meningitis Sales Value by Region
        5.1.1 Global Vaccine for Non-infectious Meningitis Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Vaccine for Non-infectious Meningitis Sales Value by Region (2019-2024)
        5.1.3 Global Vaccine for Non-infectious Meningitis Sales Value by Region (2025-2030)
        5.1.4 Global Vaccine for Non-infectious Meningitis Sales Value by Region (%), (2019-2030)
    5.2 Global Vaccine for Non-infectious Meningitis Sales Volume by Region
        5.2.1 Global Vaccine for Non-infectious Meningitis Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Vaccine for Non-infectious Meningitis Sales Volume by Region (2019-2024)
        5.2.3 Global Vaccine for Non-infectious Meningitis Sales Volume by Region (2025-2030)
        5.2.4 Global Vaccine for Non-infectious Meningitis Sales Volume by Region (%), (2019-2030)
    5.3 Global Vaccine for Non-infectious Meningitis Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        5.4.2 North America Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        5.5.2 Europe Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        5.6.2 Asia Pacific Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        5.7.2 South America Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        5.8.2 Middle East & Africa Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Value
        6.2.1 Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        6.3.2 United States Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Vaccine for Non-infectious Meningitis Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        6.4.2 Europe Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Vaccine for Non-infectious Meningitis Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        6.5.2 China Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Vaccine for Non-infectious Meningitis Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        6.6.2 Japan Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Vaccine for Non-infectious Meningitis Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        6.7.2 South Korea Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Vaccine for Non-infectious Meningitis Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        6.8.2 Southeast Asia Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Vaccine for Non-infectious Meningitis Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Vaccine for Non-infectious Meningitis Sales Value, 2019-2030
        6.9.2 India Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Vaccine for Non-infectious Meningitis Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Serum Institute
        7.1.1 Serum Institute Company Information
        7.1.2 Serum Institute Introduction and Business Overview
        7.1.3 Serum Institute Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Serum Institute Vaccine for Non-infectious Meningitis Product Offerings
        7.1.5 Serum Institute Recent Development
    7.2 Sanofi SA
        7.2.1 Sanofi SA Company Information
        7.2.2 Sanofi SA Introduction and Business Overview
        7.2.3 Sanofi SA Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Sanofi SA Vaccine for Non-infectious Meningitis Product Offerings
        7.2.5 Sanofi SA Recent Development
    7.3 Pfizer
        7.3.1 Pfizer Company Information
        7.3.2 Pfizer Introduction and Business Overview
        7.3.3 Pfizer Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Pfizer Vaccine for Non-infectious Meningitis Product Offerings
        7.3.5 Pfizer Recent Development
    7.4 Nuron Biotech
        7.4.1 Nuron Biotech Company Information
        7.4.2 Nuron Biotech Introduction and Business Overview
        7.4.3 Nuron Biotech Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Nuron Biotech Vaccine for Non-infectious Meningitis Product Offerings
        7.4.5 Nuron Biotech Recent Development
    7.5 JN-International Medical
        7.5.1 JN-International Medical Company Information
        7.5.2 JN-International Medical Introduction and Business Overview
        7.5.3 JN-International Medical Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 JN-International Medical Vaccine for Non-infectious Meningitis Product Offerings
        7.5.5 JN-International Medical Recent Development

 8 Industry Chain Analysis
    8.1 Vaccine for Non-infectious Meningitis Industrial Chain
    8.2 Vaccine for Non-infectious Meningitis Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Vaccine for Non-infectious Meningitis Sales Model
        8.5.2 Sales Channel
        8.5.3 Vaccine for Non-infectious Meningitis Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Vaccine for Non-infectious Meningitis Market Trends
    Table 2. Vaccine for Non-infectious Meningitis Market Drivers & Opportunity
    Table 3. Vaccine for Non-infectious Meningitis Market Challenges
    Table 4. Vaccine for Non-infectious Meningitis Market Restraints
    Table 5. Global Vaccine for Non-infectious Meningitis Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Company (2019-2024)
    Table 7. Global Vaccine for Non-infectious Meningitis Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Vaccine for Non-infectious Meningitis Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Vaccine for Non-infectious Meningitis Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Vaccine for Non-infectious Meningitis Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Vaccine for Non-infectious Meningitis Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Vaccine for Non-infectious Meningitis
    Table 13. Global Vaccine for Non-infectious Meningitis Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Non-infectious Meningitis as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Vaccine for Non-infectious Meningitis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Vaccine for Non-infectious Meningitis Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Vaccine for Non-infectious Meningitis Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Vaccine for Non-infectious Meningitis Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Vaccine for Non-infectious Meningitis Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Vaccine for Non-infectious Meningitis Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Vaccine for Non-infectious Meningitis Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Vaccine for Non-infectious Meningitis Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Vaccine for Non-infectious Meningitis Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Vaccine for Non-infectious Meningitis Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Vaccine for Non-infectious Meningitis Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Vaccine for Non-infectious Meningitis Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Vaccine for Non-infectious Meningitis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Vaccine for Non-infectious Meningitis Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Vaccine for Non-infectious Meningitis Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Vaccine for Non-infectious Meningitis Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Vaccine for Non-infectious Meningitis Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Vaccine for Non-infectious Meningitis Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Vaccine for Non-infectious Meningitis Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Vaccine for Non-infectious Meningitis Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Vaccine for Non-infectious Meningitis Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Vaccine for Non-infectious Meningitis Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Vaccine for Non-infectious Meningitis Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Vaccine for Non-infectious Meningitis Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Vaccine for Non-infectious Meningitis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Vaccine for Non-infectious Meningitis Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Vaccine for Non-infectious Meningitis Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Vaccine for Non-infectious Meningitis Sales Value by Region (2019-2024) & (%)
    Table 44. Global Vaccine for Non-infectious Meningitis Sales Value by Region (2025-2030) & (%)
    Table 45. Global Vaccine for Non-infectious Meningitis Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Vaccine for Non-infectious Meningitis Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Vaccine for Non-infectious Meningitis Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Vaccine for Non-infectious Meningitis Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Vaccine for Non-infectious Meningitis Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Vaccine for Non-infectious Meningitis Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Vaccine for Non-infectious Meningitis Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Volume, (2025-2030) & (K Units)
    Table 57. Serum Institute Company Information
    Table 58. Serum Institute Introduction and Business Overview
    Table 59. Serum Institute Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Serum Institute Vaccine for Non-infectious Meningitis Product Offerings
    Table 61. Serum Institute Recent Development
    Table 62. Sanofi SA Company Information
    Table 63. Sanofi SA Introduction and Business Overview
    Table 64. Sanofi SA Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi SA Vaccine for Non-infectious Meningitis Product Offerings
    Table 66. Sanofi SA Recent Development
    Table 67. Pfizer Company Information
    Table 68. Pfizer Introduction and Business Overview
    Table 69. Pfizer Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Pfizer Vaccine for Non-infectious Meningitis Product Offerings
    Table 71. Pfizer Recent Development
    Table 72. Nuron Biotech Company Information
    Table 73. Nuron Biotech Introduction and Business Overview
    Table 74. Nuron Biotech Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Nuron Biotech Vaccine for Non-infectious Meningitis Product Offerings
    Table 76. Nuron Biotech Recent Development
    Table 77. JN-International Medical Company Information
    Table 78. JN-International Medical Introduction and Business Overview
    Table 79. JN-International Medical Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. JN-International Medical Vaccine for Non-infectious Meningitis Product Offerings
    Table 81. JN-International Medical Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Vaccine for Non-infectious Meningitis Downstream Customers
    Table 85. Vaccine for Non-infectious Meningitis Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccine for Non-infectious Meningitis Product Picture
    Figure 2. Global Vaccine for Non-infectious Meningitis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Vaccine for Non-infectious Meningitis Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Vaccine for Non-infectious Meningitis Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Vaccine for Non-infectious Meningitis Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Vaccine for Non-infectious Meningitis Report Years Considered
    Figure 7. Global Vaccine for Non-infectious Meningitis Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Vaccine for Non-infectious Meningitis Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccine for Non-infectious Meningitis Revenue in 2023
    Figure 10. Vaccine for Non-infectious Meningitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Polysaccharide Vaccines Picture
    Figure 12. Conjugate Vaccines Picture
    Figure 13. Combination Vaccines Picture
    Figure 14. Men B Vaccines Picture
    Figure 15. Global Vaccine for Non-infectious Meningitis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Vaccine for Non-infectious Meningitis Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Vaccine for Non-infectious Meningitis Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Vaccine for Non-infectious Meningitis Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Vaccine for Non-infectious Meningitis Price by Type (2019-2030) & (USD/Unit)
    Figure 20. Product Picture of Meningitis
    Figure 21. Product Picture of Septicemia
    Figure 22. Product Picture of Others
    Figure 23. Global Vaccine for Non-infectious Meningitis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Vaccine for Non-infectious Meningitis Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Vaccine for Non-infectious Meningitis Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Vaccine for Non-infectious Meningitis Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Vaccine for Non-infectious Meningitis Price by Application (2019-2030) & (USD/Unit)
    Figure 28. North America Vaccine for Non-infectious Meningitis Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Vaccine for Non-infectious Meningitis Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Vaccine for Non-infectious Meningitis Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Vaccine for Non-infectious Meningitis Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Vaccine for Non-infectious Meningitis Sales Volume (%), (2019-2030)
    Figure 40. United States Vaccine for Non-infectious Meningitis Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Vaccine for Non-infectious Meningitis Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Vaccine for Non-infectious Meningitis Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Vaccine for Non-infectious Meningitis Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Vaccine for Non-infectious Meningitis Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Vaccine for Non-infectious Meningitis Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Vaccine for Non-infectious Meningitis Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Vaccine for Non-infectious Meningitis Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Vaccine for Non-infectious Meningitis Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Vaccine for Non-infectious Meningitis Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Vaccine for Non-infectious Meningitis Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Vaccine for Non-infectious Meningitis Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Vaccine for Non-infectious Meningitis Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Vaccine for Non-infectious Meningitis Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Vaccine for Non-infectious Meningitis Sales Value by Application (%), 2023 VS 2030
    Figure 61. Vaccine for Non-infectious Meningitis Industrial Chain
    Figure 62. Vaccine for Non-infectious Meningitis Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.

The global market for Vaccine for Non-infectious Meningitis was estimated to be worth US$ 1 million in 2023 and is forecast to a readjusted size of US$ 2 million by 2030 with a CAGR of 12.0% during the forecast period 2024-2030

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 104 Pages

Report ld: 2333633

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00